ECG VRD Scoring for NSTEMI Detection Without ST Elevation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting non-ST elevation myocardial infarction (NSTEMI) are suboptimal, as ST elevation on the prehospital ECG is prevalent in less than 25% of patients, leading to delayed treatment and high mortality rates, while serum cardiac enzymes are impractical for early detection.
Innovation Solution
Utilizing electrocardiographic data to quantify ventricular repolarization dispersion (VRD) and other properties to detect myocardial ischemia without STE, enhancing sensitivity by 30% to 50% through novel ECG methods and devices that calculate indices such as T wave complexity ratio and other VRD markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ST elevation is used as the principal ECG marker for risk stratification and treatment decisions, then treatment decisions can be made based on a simple marker, but sensitivity for detecting NSTEMI is low (less than 25% of patients)
Solution Approach 1:
The patent segments the ECG analysis into multiple independent components: ST elevation detection, T wave morphology analysis, and VRD calculation. Each component can be processed separately and combined to form a comprehensive diagnosis, allowing the system to maintain high sensitivity while managing complexity through modular analysis.
Solution Approach 2:
The patent introduces VRD (ventricular repolarization dispersion) as a new dimension of ECG analysis beyond traditional ST elevation. By calculating VRD from multiple ECG leads and combining it with T wave complexity metrics, the system adds analytical depth without requiring fundamentally new equipment, thereby improving detection sensitivity while leveraging existing ECG infrastructure.
2Measurement precision
If serum cardiac enzymes are used for NSTEMI diagnosis, then definitive diagnosis can be made, but treatment is delayed until enzyme elevation occurs (hours after ischemic injury)
Solution Approach 1:
The patent performs preliminary ECG analysis including VRD calculation and T wave complexity assessment immediately upon patient presentation, before serum cardiac enzymes have time to elevate. This early detection capability allows treatment to be initiated based on ECG findings alone, eliminating the waiting period required for enzyme-based diagnosis.
Solution Approach 2:
The patent uses VRD and T wave complexity metrics as intermediary markers that appear earlier than cardiac enzyme elevation. These ECG-derived parameters serve as early warning signals that precede the biochemical changes detected by troponin assays, enabling timely intervention before definitive enzyme-based diagnosis is possible.
3Productivity
If only 25% of MI patients with STE are identified, then treatment can be focused on a small subset, but 75% of NSTEMI patients experience high mortality with delayed treatment
Solution Approach 1:
The patent implements dynamic risk stratification that adapts to each patient's specific ECG characteristics. By calculating VRD and T wave complexity metrics tailored to individual patients and comparing them against population-based thresholds, the system dynamically identifies high-risk NSTEMI patients who would benefit from immediate intervention, rather than applying static criteria to all patients.
Solution Approach 2:
The patent changes the diagnostic parameters from traditional ST elevation thresholds to include VRD and T wave complexity metrics. By modifying the analytical parameters used in ECG interpretation, the system becomes sensitive to NSTEMI pathology while maintaining the ability to process patients efficiently through automated calculation and threshold-based decision support.
Data Source
AI summary
Disclosed herein are methods, systems, and devices for identifying increased likelihood of non-ST elevation myocardial infarction (NSTEMI) in a patient based on ECG data. The methods can include determining based on the ECG data that the patient lacks ST elevation (STE) and that the patient exhibits a ventricular repolarization dispersion (VRD) score that exceeds a predetermined threshold value. The VRD score can be based in part on a T wave complexity ratio that serves as a temporal marker of VRD for the patient. Other markers of spatial and time qualities of repolarization can also be included in the VRD score. An elevated VRD score in the absence of STE can indicate a likelihood of NSTEMI in the patient and a potential major adverse cardiac event.